László Kovács
5 Papers
László Kovács is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 1, co-authored 5 publications.
Chat about Author
Papers
Immunomodulatory effects of chicken cathelicidin-2 on a primary hepatic cell co-culture model
Csilla Sebők,S.E Walmsley,Patrik Tráj,Máté Mackei,Júlia Vörösházi,J. Petrilla,László Kovács,Ágnes Kemény,Zsuzsanna Neogrády,Gábor Mátis +9 more
TL;DR: Chicken cathelicidin-2 plays a substantial role in modulating the hepatic immune response with a multifaceted mode of action and was found to have dose-dependent effects on metabolic activity, membrane integrity, and reactive oxygen species production, indicating that using it in excessively high concentrations can contribute to cell damage.
11
Luteolin: A Phytochemical to Mitigate S. Typhimurium Flagellin-Induced Inflammation in a Chicken In Vitro Hepatic Model
Patrik Tráj,Csilla Sebők,Máté Mackei,Ágnes Kemény,Orsolya Farkas,László Kovács,Zsuzsanna Neogrády,Ákos Jerzsele,Gábor Mátis +8 more
TL;DR: In this article , the anti-inflammatory and antioxidant activity of luteolin (a common phytochemical of vegetables with a flavonoid structure) in a chicken hepatic cell culture was investigated.
4
In vitro susceptibility of Mycoplasma iowae isolates to antimicrobial agents
Dominika Buni,L. Udvari,Dorottya Földi,Nikolett Belecz,Cécile Yvon,Janet M. Bradbury,S. Catania,Inna Lysnyansky,László Kovács,Miklós Gyuranecz,Zsuzsa Kreizinger +10 more
TL;DR: The widely detected low susceptibility of M. iowae isolates to macrolides, lincomycin and spectinomycin, and the increase of MIC values of frequently used antimicrobials against this pathogen, emphasize the importance of targeted antibiotic therapy.
1
Pos1419 single cell analysis revealing the lectin binding pattern of t-cells, nkt-cells, nk cells, b-cells and monocyte subsets in systemic lupus erythematosus
TL;DR: In this article , the ability of certain immune subsets to bind Gal-1, Gal-3, sialic acid binding C-type lectin (Siglec-1), the fucose bindingAleuria aurantialectin (AAL), the sialIC acid bindingSambucus nigraAgglutinin (sNA) lectin in SLE patients versus healthy controls was analyzed.
Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial
Markus P. Schlaich,Marc Bellet,Michael A. Weber,Parisa Danaietash,George L. Bakris,John M. Flack,Roland F. Dreier,M. Sassi-Sayadi,Lloyd Haskell,Krzysztof Narkiewicz,Ji-Guang Wang,Christopher M. Reid,Ivor Katz,Andrew E. Ajani,Sinjini Biswas,Murray D. Esler,Grahame J Elder,Simon D. Roger,David Colquhoun,John D. Mooney,G. De Backer,Alexandre Persu,Martin Chaumont,Jean-Marie Krzesinski,Thomas Vanabsche,Ginette Girard,L Pliamm,Ernesto L. Schiffrin,Fatima S. Merali,George K. Dresser,Michel Vallée,Shivinder S. Jolly,Stephen Chow,Ji-Gwang Wang,Jianjun Mu,Jing Yu,Hong Yuan,Yingqing Feng,Xin Zhang,Jianhong Xie,Ling Lin,Miroslav Souček,J Widimsky,Renata Cifkova,Jan Václavík,Martin Ullrych,M Lukac,Ivan Rychlik,Thomas G. Lauridsen,Ilkka Kantola,Jyrki Taurio,Olavi Ukkola,Olivier Ormezzano,Philippe Gosse,Michel Azizi,Pierre-Yves Courand,Pascal Delsart,Jean-Michel Tartière,Felix Mahfoud,Roland E. Schmieder,Johannes Stegbauer,Philipp Lurz,Michael Koziolek,Christian Otte,Nicole Toursarkissian,Constantinos Tsioufis,K. Kyfnidis,Athanasios J. Manolis,Sotirios Patsilinakos,Pantelis Zebekakis,Apostolos Karavidas,Páll Dénes,Katalin Bezzegh,Marianna Zsom,László Kovács,Yehonatan Sharabi,Mazen Elias,Ivetta Sukholutsky,Chaim Yosefy,I. Kenis,Shaul Atar,Massimo Volpe,Muiesan Maria Lorenza,Stefano Taddei,Guido Grassi,Franco Veglio,Jung Woo Son,Jang Young Kim,Joong-Il Park,Chang Hoon Lee,Hae Young Lee,Rasa Raugaliene,Jolanta E. Marcinkeviciene,R. Kavaliauskiene,Jaap Deinum,Abraham A. Kroon,Bert Jan H. van den Born,Andrzej Januszewicz,Andrzej Tykarski,J. Walczewska,Zbigniew Gaciong,Andrzej Wiecek,Marzena Chrostowska,Andrzej Kleinrok,Jan Krekora,Grzegorz Kania,Anna Podrazka-Szczepaniak,Cezary Goławski,Maciej Podziewski,Barbara Kaczmarek,G.A. Skoczylas,Andrzej Wilkolaski,I. Woźniak,Marzena Janik-Palazzolo,Barbara Rewerska,Alexandra Konradi,Yu. V. Shvarts,T B Pecherina,Konstantin Nikolaev,Gapon Liudmila,O. Orlikova,Viktor Mordovin,N. V. Petrochenkova,G. Kamalov,E. D. Kosmacheva,V. V. Tyrenko,V. I. Gorbunov,A. G. Obrezan,Tatiana Vyacheslavovna Supryadkina,Irina A Ler,O.G. Kotenko,Anatoly Kuzin,Fernando Martinez,Josep Redon,Anna Oliveras,Luis Beltran Romero,V. B. Shatylo,L Rudenko,Andrii Bazylevych,Yu.Yu. Rudyk,Oleksandr Karpenko,Mykola Stanislavchuk,Vira Tseluyko,Mykola Kushnir,E. Asanov,Yuriy Sirenko,Andriy Yagensky,David A. Collier,Pankaj Gupta,David J. Webb,Mary MacLeod,James M McLay,Aaron Peace,Samir Arora,Patricia Michelle Buchanan,Robert Sean Harris,Ronald G DeGarmo,Mario Guillen,Adam D. Karns,Joel M. Neutel,Yogesh Paliwal,Karl William Pettis,Phillip D Toth,Jeffrey M. Wayne,Bain Butcher,Philip Diller,Suzanne Oparil,D. Calhoun,Donald Brautigam,Jesse Matthew Goldman,Arash Rashidi,Nabeel Aslam,William Haley,Nabil Andrawis,Brian Lang,Randy L. Miller,James Powell,Robert Dewhurst,James Pritchard,D. Khanna,Dennis Tang,Nashwa Gabra,Jean-Ho Park,Conigliaro Jones,Cranford L. Scott,Blanca Alicia Luna,Murtaza Mussaji,Ravi Bhagwat,Michael Bauer,J M McGinty,R. Nambiar,Renee Sangrigoli,William R. Davis,William Eaves,Frank McGrew,Ahmed Hamdy Awad,E.J. Bolster,David Scott,Paramjit Kalirao,Pascal Dabel,Wesley B. Calhoun,Steven F. Gouge,Mark B. Warren,M. K. Lawrence,Aamir Jamal,Mohamed A. El-Shahawy,C. Mercado,Jayant Kumar,Pedro Velasquez-Mieyer,Robert Busch,Todd Lewis,Lisa Rich +211 more
TL;DR: Assessment of the blood pressure lowering efficacy of the dual endothelin antagonist aprocitentan in patients with resistant hypertension found it well tolerated and superior to placebo in lowering blood pressure at week 4 with a sustained effect at week 40.